nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—CYP2C19—Teniposide—lymphatic system cancer	0.213	0.31	CbGbCtD
Tolbutamide—SLCO1A2—Methotrexate—lymphatic system cancer	0.186	0.269	CbGbCtD
Tolbutamide—CYP2C9—Teniposide—lymphatic system cancer	0.177	0.257	CbGbCtD
Tolbutamide—SLC22A6—Methotrexate—lymphatic system cancer	0.113	0.163	CbGbCtD
Tolbutamide—Digestion impaired—Fludarabine—lymphatic system cancer	0.0176	0.0566	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Mechlorethamine—lymphatic system cancer	0.0146	0.047	CcSEcCtD
Tolbutamide—Inappropriate antidiuretic hormone secretion—Vincristine—lymphatic system cancer	0.0124	0.0398	CcSEcCtD
Tolbutamide—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.0108	0.0348	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Teniposide—lymphatic system cancer	0.0108	0.0346	CcSEcCtD
Tolbutamide—Reaction gastrointestinal—Methotrexate—lymphatic system cancer	0.0105	0.0336	CcSEcCtD
Tolbutamide—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.00949	0.0305	CcSEcCtD
Tolbutamide—Pancytopenia—Teniposide—lymphatic system cancer	0.00799	0.0257	CcSEcCtD
Tolbutamide—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00712	0.0229	CcSEcCtD
Tolbutamide—Pancytopenia—Fludarabine—lymphatic system cancer	0.00702	0.0226	CcSEcCtD
Tolbutamide—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00635	0.0204	CcSEcCtD
Tolbutamide—Eruption—Methotrexate—lymphatic system cancer	0.00568	0.0182	CcSEcCtD
Tolbutamide—Hyponatraemia—Carmustine—lymphatic system cancer	0.0055	0.0177	CcSEcCtD
Tolbutamide—Hyponatraemia—Vincristine—lymphatic system cancer	0.00525	0.0169	CcSEcCtD
Tolbutamide—Leukopenia—Teniposide—lymphatic system cancer	0.00525	0.0169	CcSEcCtD
Tolbutamide—Pancytopenia—Bleomycin—lymphatic system cancer	0.00515	0.0165	CcSEcCtD
Tolbutamide—Hyponatraemia—Mitoxantrone—lymphatic system cancer	0.00511	0.0164	CcSEcCtD
Tolbutamide—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00468	0.015	CcSEcCtD
Tolbutamide—Leukopenia—Fludarabine—lymphatic system cancer	0.00461	0.0148	CcSEcCtD
Tolbutamide—Pruritus—Mechlorethamine—lymphatic system cancer	0.00459	0.0147	CcSEcCtD
Tolbutamide—Pancytopenia—Carmustine—lymphatic system cancer	0.00449	0.0144	CcSEcCtD
Tolbutamide—Pancytopenia—Vincristine—lymphatic system cancer	0.00429	0.0138	CcSEcCtD
Tolbutamide—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00418	0.0134	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00412	0.0132	CcSEcCtD
Tolbutamide—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00412	0.0132	CcSEcCtD
Tolbutamide—Rash—Mechlorethamine—lymphatic system cancer	0.00409	0.0131	CcSEcCtD
Tolbutamide—Nausea—Mechlorethamine—lymphatic system cancer	0.00385	0.0124	CcSEcCtD
Tolbutamide—Urticaria—Teniposide—lymphatic system cancer	0.0038	0.0122	CcSEcCtD
Tolbutamide—Erythema—Bleomycin—lymphatic system cancer	0.00378	0.0121	CcSEcCtD
Tolbutamide—Dyspepsia—Fludarabine—lymphatic system cancer	0.0037	0.0119	CcSEcCtD
Tolbutamide—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00366	0.0118	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00363	0.0117	CcSEcCtD
Tolbutamide—Pruritus—Teniposide—lymphatic system cancer	0.00338	0.0109	CcSEcCtD
Tolbutamide—Leukopenia—Bleomycin—lymphatic system cancer	0.00338	0.0109	CcSEcCtD
Tolbutamide—Erythema—Carmustine—lymphatic system cancer	0.0033	0.0106	CcSEcCtD
Tolbutamide—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00328	0.0105	CcSEcCtD
Tolbutamide—Erythema—Mitoxantrone—lymphatic system cancer	0.00306	0.00985	CcSEcCtD
Tolbutamide—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00302	0.0097	CcSEcCtD
Tolbutamide—Rash—Teniposide—lymphatic system cancer	0.00302	0.00969	CcSEcCtD
Tolbutamide—Headache—Teniposide—lymphatic system cancer	0.003	0.00963	CcSEcCtD
Tolbutamide—Pruritus—Fludarabine—lymphatic system cancer	0.00297	0.00956	CcSEcCtD
Tolbutamide—Leukopenia—Carmustine—lymphatic system cancer	0.00295	0.00948	CcSEcCtD
Tolbutamide—Nausea—Teniposide—lymphatic system cancer	0.00284	0.00913	CcSEcCtD
Tolbutamide—Leukopenia—Vincristine—lymphatic system cancer	0.00282	0.00905	CcSEcCtD
Tolbutamide—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00274	0.00881	CcSEcCtD
Tolbutamide—Rash—Fludarabine—lymphatic system cancer	0.00265	0.00852	CcSEcCtD
Tolbutamide—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00263	0.00846	CcSEcCtD
Tolbutamide—Headache—Fludarabine—lymphatic system cancer	0.00263	0.00846	CcSEcCtD
Tolbutamide—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00251	0.00808	CcSEcCtD
Tolbutamide—Nausea—Fludarabine—lymphatic system cancer	0.0025	0.00802	CcSEcCtD
Tolbutamide—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00245	0.00787	CcSEcCtD
Tolbutamide—Urticaria—Bleomycin—lymphatic system cancer	0.00245	0.00787	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00232	0.00746	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00222	0.00712	CcSEcCtD
Tolbutamide—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.0022	0.00707	CcSEcCtD
Tolbutamide—Pruritus—Bleomycin—lymphatic system cancer	0.00218	0.00701	CcSEcCtD
Tolbutamide—Pancytopenia—Methotrexate—lymphatic system cancer	0.00208	0.00669	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.002	0.00643	CcSEcCtD
Tolbutamide—Urticaria—Mitoxantrone—lymphatic system cancer	0.00199	0.00638	CcSEcCtD
Tolbutamide—Rash—Bleomycin—lymphatic system cancer	0.00194	0.00624	CcSEcCtD
Tolbutamide—Nausea—Bleomycin—lymphatic system cancer	0.00183	0.00588	CcSEcCtD
Tolbutamide—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00182	0.00586	CcSEcCtD
Tolbutamide—Rash—Carmustine—lymphatic system cancer	0.0017	0.00545	CcSEcCtD
Tolbutamide—Headache—Carmustine—lymphatic system cancer	0.00169	0.00542	CcSEcCtD
Tolbutamide—Rash—Vincristine—lymphatic system cancer	0.00162	0.0052	CcSEcCtD
Tolbutamide—Headache—Vincristine—lymphatic system cancer	0.00161	0.00517	CcSEcCtD
Tolbutamide—Nausea—Carmustine—lymphatic system cancer	0.0016	0.00514	CcSEcCtD
Tolbutamide—Rash—Mitoxantrone—lymphatic system cancer	0.00158	0.00507	CcSEcCtD
Tolbutamide—Headache—Mitoxantrone—lymphatic system cancer	0.00157	0.00503	CcSEcCtD
Tolbutamide—Erythema—Methotrexate—lymphatic system cancer	0.00153	0.00491	CcSEcCtD
Tolbutamide—Nausea—Vincristine—lymphatic system cancer	0.00153	0.0049	CcSEcCtD
Tolbutamide—Nausea—Mitoxantrone—lymphatic system cancer	0.00149	0.00477	CcSEcCtD
Tolbutamide—Leukopenia—Methotrexate—lymphatic system cancer	0.00137	0.00439	CcSEcCtD
Tolbutamide—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00122	0.00392	CcSEcCtD
Tolbutamide—Dyspepsia—Methotrexate—lymphatic system cancer	0.0011	0.00352	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00108	0.00346	CcSEcCtD
Tolbutamide—Urticaria—Methotrexate—lymphatic system cancer	0.00099	0.00318	CcSEcCtD
Tolbutamide—Pruritus—Methotrexate—lymphatic system cancer	0.000882	0.00283	CcSEcCtD
Tolbutamide—Rash—Methotrexate—lymphatic system cancer	0.000786	0.00252	CcSEcCtD
Tolbutamide—Headache—Methotrexate—lymphatic system cancer	0.000781	0.00251	CcSEcCtD
Tolbutamide—Nausea—Methotrexate—lymphatic system cancer	0.00074	0.00238	CcSEcCtD
